Advances in Human Biology

REVIEW ARTICLE
Year
: 2018  |  Volume : 8  |  Issue : 2  |  Page : 54--58

Antibiotics in chronic rhinosinusitis: A brief synopsis of literatures


Muhamad Bin Abu Bakar, Mainul Haque 
 Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, 57000 Kuala Lumpur, Malaysia

Correspondence Address:
Mainul Haque
Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, 57000 Kuala Lumpur
Malaysia

Abstract

Sinusitis is an inflammation or else infection of the nose and paranasal sinuses. These cavities are adjacent, and any provocative or transferrable process that touches one also communicates and contaminates others. Consequently, the important entity in this regard to remember that the befitting locution is: rhinosinusitis preferably apart from sinusitis. Chronic sinusitis, more accurately termed chronic rhinosinusitis (CRS), is diagnosed more often than acute rhinosinusitis (ARS). Rhinosinusitis is founded on the four key symptoms of 'obstruction, drainage, smell loss and facial pain or pressure' in both ARS and CRS. CRS relates to a progressive upsurge in healthcare exploitation, expenses and healthcare cost remains high. It has been estimated that widespread antimicrobials prescribing and use for CRS cost in the USA was more than the US $150 million to 2.4 billion per year and in the UK, it is about ≤10 million, which finally promotes antimicrobial resistance (AMR). Multiple meta-analyses revealed that the respiratory fluoroquinolones (specifically moxifloxacin, levofloxacin and gatifloxacin) were not able to establish superiority to β-lactams and other classes of antimicrobials for the management of ARS regarding the efficacy and ADR. Thereafter, three additional meta-analyses revealed that there were no corroboration and affirmation of superior efficacy, usefulness and lower adverse effects observed with any definite group of antibiotics in sinusitis. The current understanding regarding the pathophysiology of CRS microbial infection cannot be established, and antimicrobials role should be dedicated in the management ARS episodes or their contagious impediments, and the choice of antimicrobials should be channeled by optimally obtained on endoscopic sinus culture.



How to cite this article:
Abu Bakar MB, Haque M. Antibiotics in chronic rhinosinusitis: A brief synopsis of literatures.Adv Hum Biol 2018;8:54-58


How to cite this URL:
Abu Bakar MB, Haque M. Antibiotics in chronic rhinosinusitis: A brief synopsis of literatures. Adv Hum Biol [serial online] 2018 [cited 2019 Dec 6 ];8:54-58
Available from: http://www.aihbonline.com/text.asp?2018/8/2/54/232030


Full Text

 Introduction



Sinusitis is an inflammation or else infection of the nose and paranasal sinuses. These cavities are adjacent, and any provocative or transferrable process that touches one also communicates and contaminates others. Consequently, the important entity in this regard to remember that the befitting locution is: rhinosinusitis preferably apart from sinusitis.[1] Other groups of scientists describe the term rhinosinusitis is chosen since sinusitis seldom ensues in the absence of rhinitis, and 'the nose and sinuses are contiguous structures sharing vascular, neuronal, and interconnecting anatomic pathways'.[2] Chronic sinusitis is one of the more predominant chronic debilitating illnesses in both developed and developing countries of this planet, distressing persons of all age clusters.[3],[4],[5],[6] Acute bacterial sinusitis generally ensues subsequent an upper respiratory infection (URI) that outcomes in impediment of the 'osteomeatal complex, impaired mucociliary clearance and overproduction of secretions'.[7] Acute sinusitis continues for <8 weeks, and chronic sinusitis of a single episode can persist from 12 weeks to years.[8],[9] Chronic sinusitis, more accurately termed chronic rhinosinusitis (CRS), is diagnosed more often than acute rhinosinusitis (ARS).[10] Rhinosinusitis is founded on the four key symptoms of 'obstruction, drainage, smell loss and facial pain or pressure' in both ARS and CRS.[9] CRS to diagnosis and management the up-to-date recommendation divided CRS into two subcategories demarcated by the presence or absence of nasal polyps (NPs): CRS with NP (CRSwNP) and CRS without NP (CRSsNP).[11],[12],[13],[14]

 Socioeconomic Impact of Chronic Rhinosinusitis



CRS relates to a progressive upsurge in healthcare exploitation, expenses and healthcare cost remains high.[15] One study from the USA reported that direct costs associated with CRS are principally determined by recurrent doctors' consultation, cost of medicine and necessary surgery.[16],[17] CRS induces sizable ancillary costs and frequently fluctuate grounded on the severity of CRS-specific quality of life loss. The general direct and indirect cost related to CRS is estimated $10–13 and more than 20 billion per year in the USA, respectively.[15] Indirect cost because of inadequate work both of quality and quantity.[17] One systematic review had confirmed that considerable direct and indirect costs linked with CRS.[18] One more US study revealed that a major proportion of CRS patient requires intervention for very prolong period that increases the overall cost. Sinus surgery appears to reduce the overall healthcare expenditure, but the surgical intervention itself is the costly procedure.[19] It has been estimated that widespread antimicrobials prescribing and use for CRS cost in the USA was more than the US $150 million to 2.4 billion per year and in the UK, it is about ≤10 million, which finally promotes antimicrobial resistance (AMR).[14],[20],[21]

 Treatment Strategies for Chronic Rhinosinusitis



Sinusitis is very common throughout the planet. Consequently, it is imperative to comprehend its 'pathophysiology, diagnosis and medical and surgical treatments'.[22] CRS has been identified as an intricate disease comprising quite a few disease deviations with diverse concealed and hidden pathophysiologies; it is much more than an infective disorder.[2],[23] Yet pathophysiologies of CRS were not completely understood, especially of subgroups is perhaps the utmost difficulty in refining treatment strategies.[2],[23] The aim medical treatment for CRS is to diminish mucosal oedema, reassure sinus drainage and exterminate if infections present. Medical treatment frequently necessitates an amalgamation of topical glucocorticoids, systemic antibiotics and nasal saline irrigation.[2] Treating CRS often demand antimicrobials much more prolong duration than that of ARS, nonetheless not all patients with the radiographic sign of CRS necessitate antimicrobial medicine.[24] A recent study reported that CRS in adults is an inflammatory disease if possible than an infective disorder. CRS smear cultures in revealing a concoction of aerobes and anaerobes; nevertheless, whether these microbes were colonisers microbiome or invading organism to create symptoms are unknown.[9] After this, the role of antimicrobials remains elusive.[9] Similarly, another study reported that regardless of the consistent presence of microorganisms in the sinuses, but it was not proved that primary aetiology of CRS still not explained.[6] Subsequently, this similarly concluded that CRS is an inflammatory disease correlated with either noneosinophilic inflammatory or eosinophilic sinusitis. Eosinophilic sinusitis comprises at least two conditions, including aspirin-exacerbated respiratory disease and most commonly, chronic hyperplastic eosinophilic sinusitis (CHES).[6] CHES is an illness of the upper respiratory tract that reflects the disease of the lower airways that is repeatedly parallelly expressed in patients with asthma.[25] Individually, these inflammatory conditions need to be addressed with a distinct treatment plan.[6]

 Antibiotics in Chronic Rhinosinusitis



AMR is now an important problem of our planet and has been identified as a serious and critical issue for public health.[26],[27],[28],[29],[30],[31] AMR has amplified by the overuse promotes severe infections, complications, longer hospital stays and increased mortality. Overprescribing of antibiotics is often linked higher rate of adverse drug reactions (ADRs), more frequent reattendance and increased medicalisation of self-limiting conditions such common viral infections.[26] It has been reported that inadequate treatment of ARS proceed to CRS is associated with a corresponding change in the microbiology of the disease. The shift in microbiology from acute to CRS favours infection with Staphylococcus aureus, Staphylococcus epidermidis, anaerobic bacteria (including beta-lactamase-producing strains) and Gram-negative bacteria.[32] Dr. Bradley Marple, an ear-nose-and-throat surgeon at the University of Texas Southwestern Medical Center in Dallas, said that CRS as being perhaps further of an inflammatory disease process. Therefore, antimicrobials had not much role in CRS.[33] Dr. Rob Ivker reported that in treating patients with sinusitis and almost all respiratory conditions, for the past 30 years of his practice, antibiotics are not at all effective.[34] Another randomised, placebo-controlled trial reported that antibiotics compared with placebo offers little clinical well-being and comfort for majority patients diagnosed with ARS.[35] As multiple studies reported that the majority of ARS and CRS were due to inflammatory, viral or fungal, not the bacterial cause.[36],[37],[38],[39] Moreover, antimicrobials kill friendly bacteria microbiome of gastrointestinal and other areas of the human body which potentiates fungal sinusitis.[37],[40],[41]

In the UK, 37%–63% of patients presenting with symptoms of sinusitis do not have reliably confirmed the diagnosis. Henceforth, a minor group of patients had dependably completed diagnosis by a physician.[42],[43],[44],[45],[46],[47] Regardless of the clinical ambiguity of bacterial cause of ARS and CRS in commonplace practice, antimicrobials prescribing rates in the UK, the USA, the Netherland and Norway were 92%, 85%–98%, 80% and 67%, respectively.[48],[49],[50],[51] The reason for such overprescribing of antibiotics as there were no acceptable research studies were conducted for primary care patients for the microbiological aetiology of ARS and CRS even in developed countries.[52],[53] Multiple meta-analyses and research studies revealed that very little clinical well-being achieved with antibiotic treatment. These analyses found clinical improvement of sinusitis were attained basically spontaneously.[54],[55],[56],[57],[58],[59] Moreover, prescribed antibiotics often fail to reach infection site poor therapeutic concentration.[58] Multiple meta-analyses revealed that the respiratory fluoroquinolones (specifically moxifloxacin, levofloxacin and gatifloxacin) were not able to establish superiority to β-lactams and other classes of antimicrobials for the management of ARS regarding the efficacy and ADR.[60],[61],[62] Thereafter, three additional meta-analyses revealed that there were no corroboration and affirmation of superior efficacy, usefulness and lower adverse effects observed with any definite group of antibiotics in sinusitis.[55],[61],[63]

 Glucocorticoids, Saline Nasal Irrigation, Use in Chronic Rhinosinusitis



CRS is a multifarious medical disorder that often had significant adverse impact on patient quality of life, the social order, increases healthcare costs and current available treatment options proven insufficient.[11],[13],[64],[65] The nonspecific and specific immune system and its composite relationship are progressively more being documented as significant aspects in the pathogenesis of CRS.[11],[66],[67] The resident and inflammatory cells of acquired immune components, as well as, and their associated chemical mediators, have been the patient of most research in CRS.[11] Thereafter, the mainstay of the treatment CRS systemic antibiotics was now quickly replacing with innovative anti-inflammatory therapies.[66]

Saline nasal irrigation (SNI), a remedy with roots in Ayurvedic medicine that washes the nasal mucosa with saline water, had been utilised for multiple upper respiratory diseases, for example, ARS, CRS, viral URI and allergic rhinitis.[65] The utilisation SNI for the upper respiratory disease had been reported dated back to 1902.[68] SNI had been recognised as 'an important component in the management of the most sinonasal conditions'.[69] SNI is effective with low potential of ADRs; even ADRs occurs were minimum and transient but very poorly utilised this very cheap, safe procedure.[64],[68],[70] Large volumes, low-pressure saline irrigation had improved symptoms in non-post-operative and post-endoscopic sinus surgery (ESS) CRS patients measured using the Sino-Nasal Outcome Test-20 in randomised controlled trials.[71],[72] Thereafter, another evidence-based review and meta-analysis recommended SNI therapy approaches improve CRS related symptoms, health-related quality of life, an admirable safety outline, major health benefit over ADRs and saves health budget of the country and the individual.[73]

 Endoscopic Sinus Surgery on Patients with Chronic Rhinosinusitis



ESS is most frequently done for inflammatory and infectious sinus disease. The most common indications for ESS are as follows: (i) CRS refractory to medical treatment, (ii) recurrent sinusitis, (iii) nasal polyposis, (iv) antrochoanal polyps, (v) sinus mucoceles, (vi) excision of selected tumours, (vii) cerebrospinal fluid leak closure, (viii) orbital decompression (e.g. graves ophthalmopathy), (ix) optic nerve decompression, (x) dacryocystorhinostomy, (xi) choanal atresia repair, (xii) foreign body removal and (xiii) Epistaxis control.[74],[75] Functional ESS (FESS) is a type surgery of sinus conducted through the nose utilising endoscopes and inciting no external scars, is an innovative method in the management armamentarium of sinus disorder.[75] 'FESS is a minimally invasive technique used to restore sinus ventilation and normal function. The most suitable candidates for this procedure have recurrent ARS and CRS, and an improvement in symptoms of up to 90% may be expected following the procedure'.[76] One prospective study conducted at a zonal and tertiary care referral hospital of India revealed that patients with CRSwNP and CRSsNP statistically significant improvement after ESS. It was also observed that long-term follow-up had been reduced among patients with CRSwNP.[77] Another study revealed that CRSwNP and bronchial asthma certainly correlated with CRS.[78] Multiple research studies concluded that FESS had achieved clinical improvement on subjective and objective measurements of CRS.[75],[78],[79] Another the US study reported that FEES procedure had able minimize leading symptoms of CRS reasonably; however, the magnitude of improvement was lower than expected. The best outcomes were attained through FEES were an improvement of the nasal passage, chronic bad breath and hallucination of a disagreeable odour. The best result was obtained with greater improvement in life quality CRSwNP among patients than CRSsNP.[80] Another prospective longitudinal cohort study reported that ESS significantly improves symptoms of CRS and the quality of life. However, ESS alone could not able alter certain aspects of the complex pathophysiology of CRS.[81] Afterwards, constant and continuing follow-up is of the principle for the management CRS.[81] One more prospective study found that FESS highly effective in controlling symptoms of CRSwNP (80.5%) or CRSsNP (83.74%). This study subjectively assessed the overall clinical improvement after the surgery.[82] This study [82] claimed that the overall success rate of FESS was very satisfactory (80.5%–83.74%) and multiple earlier studies revealed similar improvement rate (80%–90%).[80],[83],[84],[85],[86],[87],[88]

 Conclusions



The current understanding regarding the pathophysiology of CRS microbial infection cannot be established, and antimicrobials role should be dedicated in the management ARS episodes or their contagious impediments, and the choice of antimicrobials should be channeled by optimally obtained on endoscopic sinus cultures.[6],[9],[32]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1Havas ENT Clinics. Excellence in Otolaryngology. Sinusitis. Available from: http://www.earnosethroat.com.au/sydney-nose-clinic/sinusitis/. [Last accessed on 2017 Dec 10].
2Brook I. Chronic Sinusitis. Drugs & Diseases, Infectious Diseases. Medscape; 2017. Available from: https://www.emedicine.medscape.com/article/232791-overview. [Last accessed on 2017 Dec 10].
3Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 2005;4:2.
4Nugent R. Chronic diseases in developing countries: Health and economic burdens. Ann N Y Acad Sci 2008;1136:70-9.
5Fagnan LJ. Acute sinusitis: A cost-effective approach to diagnosis and treatment. Am Fam Physician 1998;58:1795-802, 805-6.
6Kennedy JL, Borish L. Chronic rhinosinusitis and antibiotics: The good, the bad, and the ugly. Am J Rhinol Allergy 2013;27:467-72.
7Brager RJ. Acute Sinusitis vs. Chronic Sinusitis. Virginia Ear Nose & Throat. Available from: http://www.virginia-ent.com/blog/acute-sinusitis-vs-chronic-sinusitis/. [Last accessed on 2017 Dec 10].
8Tan BK, Kern RC, Schleimer RP, Schwartz BS. Chronic rhinosinusitis: The unrecognized epidemic. Am J Respir Crit Care Med 2013;188:1275-7.
9Barshak MB, Durand ML. The role of infection and antibiotics in chronic rhinosinusitis. Laryngoscope Investig Otolaryngol 2017;2:36-42.
10Bhattacharyya N. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Ann Otol Rhinol Laryngol 2011;120:423-7.
11Cain RB, Lal D. Update on the management of chronic rhinosinusitis. Infect Drug Resist 2013;6:1-4.
12Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012;50:1-2.
13Steinke JW, Borish L. Chronic rhinosinusitis phenotypes. Ann Allergy Asthma Immunol 2016;117:234-40.
14Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European academy of allergy and clinical immunology and the American academy of allergy, asthma & immunology. J Allergy Clin Immunol 2013;131:1479-90.
15Rudmik L. Economics of chronic rhinosinusitis. Curr Allergy Asthma Rep 2017;17:20.
16Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004;193:3-5.
17Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: A systematic review. Laryngoscope 2015;125:1547-56.
18Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: A claims-based study. Otolaryngol Head Neck Surg 2011;144:440-5.
19Bhattacharyya N. The economic burden and symptom manifestations of chronic rhinosinusitis. Am J Rhinol 2003;17:27-32.
20Osguthorpe JD, Hadley JA. Rhinosinusitis. Current concepts in evaluation and management. Med Clin North Am 1999;83:27-41, vii-viii.
21McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003;9:424-30.
22Radojicic C. Sinusitis: Allergies, antibiotics, aspirin, asthma. Cleve Clin J Med 2006;73:671-8.
23Statham MM, Seiden A. Potential new avenues of treatment for chronic rhinosinusitis: An anti-inflammatory approach. Otolaryngol Clin North Am 2005;38:1351-65, xi.
24Wagner W. Changing diagnostic and treatment strategies for chronic sinusitis. Cleve Clin J Med 1996;63:396-405.
25Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA, Tarara JE, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: Is the histopathology similar to asthma? J Allergy Clin Immunol 2003;112:877-82.
26Llor C, Bjerrum L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 2014;5:229-41.
27Ranjbar M, Mohammad Alizadeh AH, Pazhooh HK, Kashani KM, Golmohammadi M, Nojomi M, et al. Nosocomial infections and antimicrobial resistance pattern in a tertiary referral hospital in Hamedan, Iran. Int J Crit Illn Inj Sci 2012;2:46-7.
28Haque M, Rahman NI, Zulkifli Z, Ismail S. Antibiotic prescribing and resistance: Knowledge level of medical students of clinical years of university Sultan Zainal Abidin, Malaysia. Ther Clin Risk Manag 2016;12:413-26.
29Hoque R, Mostafa A, Haque M. Insight of medical students of clinical years to antimicrobials prescribing and resistance in private medical school, chittagong, Bangladesh. J Young Pharm 2016;8:447-55.
30Hoque R, Mostafa A, Haque M. Intern doctors' views on the current and future antibiotic resistance situation of Chattagram Maa O Shishu hospital medical college, Bangladesh. Ther Clin Risk Manag 2015;11:1177-85.
31Farahani F, Mashouf RY, Hashemian F, Esmaeili R. Antimicrobial resistance patterns of aerobic organisms in patients with chronic rhinosinusitis in Hamadan, Iran. Avicenna J Clin Microb Infec 2014;1:e18961.
32Brook I. Bacterial infection and antibiotic treatment in chronic rhinosinusitis. Clin Allergy Immunol 2007;20:147-62.
33Chen I. When Sinus Problems Won't Go Away. The New York Times; 2011. Available from: http://www.nytimes.com/ref/health/healthguide/esn-sinusitis-ess.html. [Last accessed on 2017 Dec 12].
34Ivker R. The Shocking Truth About Antibiotics; 2017. Available from: https://www.sinussurvival.com/antibiotics/. [Last accessed on 2017 Dec 12].
35Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: A randomized controlled trial. JAMA 2012;307:685-92.
36Mayo Clinic Staff. Acute Sinusitis. Patient Care & Health Information, Diseases & Conditions. Mayo Clinic. Available from: https://www.mayoclinic.org/diseases-conditions/acute-sinusitis/symptoms-causes/syc-20351671. [Last accessed on 2017 Dec 12].
37Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877-84.
38Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: A synopsis of recent consensus guidelines. Mayo Clin Proc 2011;86:427-43.
39Piromchai P, Kasemsiri P, Laohasiriwong S, Thanaviratananich S. Chronic rhinosinusitis and emerging treatment options. Int J Gen Med 2013;6:453-64.
40Ivker RS, Silvers WS, Anderson RA. Clinical observations and seven-and-one-half-year follow-up of patients using an integrative holistic approach for treating chronic sinusitis. Altern Ther Health Med 2009;15:36-43.
41Richards L. Sinus Infections and Candida Overgrowth: Are They Linked? The Candida Diet; 2017. Available from: https://www.thecandidadiet.com/sinus-infections-and-candida-linked/. [Last accessed on 2017 Dec 12].
42Lau J, Zucker D, Engels EA, Balk E, Barza M, Terrin N, et al. Diagnosis and treatment of acute bacterial rhinosinusitis: Summary. March, 1999. In: AHRQ Evidence Report Summaries. Rockville (MD): Agency for Healthcare Research and Quality (US); 1998-2005. p. 9. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11860/. [Last accessed on 2017 Dec 12].
43Lund VJ. Rhinosinusitis. Br J Hosp Med 1997;57:308-12.
44Lindbaek M, Hjortdahl P, Johnsen UL. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: Comparison with computed tomography. Fam Med 1996;28:183-8.
45Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995;311:233-6.
46Williams JW Jr., Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med 1992;117:705-10.
47van Duijn NP, Brouwer HJ, Lamberts H. Use of symptoms and signs to diagnose maxillary sinusitis in general practice: Comparison with ultrasonography. BMJ 1992;305:684-7.
48Ashworth M, Charlton J, Ballard K, Latinovic R, Gulliford M. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000. Br J Gen Pract 2005;55:603-8.
49Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: Background. Ann Intern Med 2001;134:498-505.
50Akkerman AE, van der Wouden JC, Kuyvenhoven MM, Dieleman JP, Verheij TJ. Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother 2004;54:1116-21.
51Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice – A review. Br J Gen Pract 2002;52:491-5.
52Williams JW Jr., Simel DL. Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA 1993;270:1242-6.
53Williamson I, Benge S, Moore M, Kumar S, Cross M, Little P, et al. Acute sinusitis: Which factors do FPs believe are most diagnostic and best predict antibiotic efficacy? J Fam Pract 2006;55:789-96.
54Falagas ME, Giannopoulou KP, Vardakas KZ, Dimopoulos G, Karageorgopoulos DE. Comparison of antibiotics with placebo for treatment of acute sinusitis: A meta-analysis of randomised controlled trials. Lancet Infect Dis 2008;8:543-52.
55de Ferranti SD, Ioannidis JP, Lau J, Anninger WV, Barza M. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ 1998;317:632-7.
56Garbutt JM, Goldstein M, Gellman E, Shannon W, Littenberg B. A randomized, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis. Pediatrics 2001;107:619-25.
57Merenstein D, Whittaker C, Chadwell T, Wegner B, D'Amico F. Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial. J Fam Pract 2005;54:144-51.
58Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: A randomized controlled trial. JAMA 2007;298:2487-96.
59Ahovuo-Saloranta A, Borisenko OV, Kovanen N, Varonen H, Rautakorpi UM, Williams JW Jr., et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008;2:CD000243.
60Karageorgopoulos DE, Giannopoulou KP, Grammatikos AP, Dimopoulos G, Falagas ME. Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: A meta-analysis of randomized controlled trials. CMAJ 2008;178:845-54.
61Williams JW Jr., Aguilar C, Cornell J, Chiquette ED, Makela M, Holleman DR, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2003;2:CD000243.
62Ip S, Fu L, Balk E, Chew P, Devine D, Lau J. Update on acute bacterial rhinosinusitis: Summary. June, 2005. In: AHRQ Evidence Report Summaries. Rockville (MD): Agency for Healthcare Research and Quality (US); 1998-2005. p. 124. Available from: https://www.ncbi.nlm.nih.gov/books/NBK11927/. [Last accessed on 2017 Dec 13].
63de Bock GH, Dekker FW, Stolk J, Springer MP, Kievit J, van Houwelingen JC, et al. Antimicrobial treatment in acute maxillary sinusitis: A meta-analysis. J Clin Epidemiol 1997;50:881-90.
64Rabago D, Zgierska A. Saline nasal irrigation for upper respiratory conditions. Am Fam Physician 2009;80:1117-9.
65Rama S, Ballentyne R, Hymes A. Science of Breath: A Practical Guide. Honesdale PA: The Himalayan Institute Press; 1998.
66Lee SH. Mechanisms of glucocorticoid action in chronic rhinosinusitis. Allergy Asthma Immunol Res 2015;7:534-7.
67Stevens WW, Lee RJ, Schleimer RP, Cohen NA. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol 2015;136:1442-53.
68Wingrave W. The nature of discharges and douches. Lancet 1902;159:1373-5.
69Brown CL, Graham SM. Nasal irrigations: Good or bad? Curr Opin Otolaryngol Head Neck Surg 2004;12:9-13.
70American Academy of Family Physicians. Patient information. Saline nasal irrigation for sinus problems. Am Fam Physician 2009;80:1121.
71Pynnonen MA, Mukerji SS, Kim HM, Adams ME, Terrell JE. Nasal saline for chronic sinonasal symptoms: A randomized controlled trial. Arch Otolaryngol Head Neck Surg 2007;133:1115-20.
72Liang KL, Su MC, Tseng HC, Jiang RS. Impact of pulsatile nasal irrigation on the prognosis of functional endoscopic sinus surgery. J Otolaryngol Head Neck Surg 2008;37:148-53.
73Rudmik L, Hoy M, Schlosser RJ, Harvey RJ, Welch KC, Lund V, et al. Topical therapies in the management of chronic rhinosinusitis: An evidence-based review with recommendations. Int Forum Allergy Rhinol 2013;3:281-98.
74Patel A. Functional Endoscopic Sinus Surgery. Medscape; 2016. Available from: https://www.emedicine.medscape.com/article/863420-overview. [Last accessed on 2017 Dec 14].
75Luong A, Marple BF. Sinus surgery: Indications and techniques. Clin Rev Allergy Immunol 2006;30:217-22.
76Slack R, Bates G. Functional endoscopic sinus surgery. Am Fam Physician 1998;58:707-18.
77Nair S, Dutta A, Rajagopalan R, Nambiar S. Endoscopic sinus surgery in chronic rhinosinusitis and nasal polyposis: A comparative study. Indian J Otolaryngol Head Neck Surg 2011;63:50-5.
78Proimos E, Papadakis CE, Chimona TS, Kiagiadaki D, Ferekidis E, Yiotakis J, et al. The effect of functional endoscopic sinus surgery on patients with asthma and CRS with nasal polyps. Rhinology 2010;48:331-8.
79Tan BK, Lane AP. Endoscopic sinus surgery in the management of nasal obstruction. Otolaryngol Clin North Am 2009;42:227-40, vii.
80Bunzen DL, Campos A, Leão FS, Morais A, Sperandio F, Caldas Neto S, et al. Efficacy of functional endoscopic sinus surgery for symptoms in chronic rhinosinusitis with or without polyposis. Braz J Otorhinolaryngol 2006;72:242-6.
81Mascarenhas JG, da Fonseca VM, Chen VG, Itamoto CH, Silva CA, Gregório LC, et al. Long-term outcomes of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyps. Braz J Otorhinolaryngol 2013;79:306-11.
82Basílio FM, Arantes MC, Ballin AC, Dallagnol MR, Bornhausen MB, Szkudlarek DC, et al. Efficacy of endoscopic sinus surgery in the treatment of chronic rhinosinusitis. Int Arch Otorhinolaryngol 2010;14:433-7.
83Kaliner MA, Osguthorpe JD, Fireman P, Anon J, Georgitis J, Davis ML, et al. Sinusitis: Bench to bedside. Current findings, future directions. J Allergy Clin Immunol 1997;99:S829-48.
84Levine HL. Functional endoscopic sinus surgery: Evaluation, surgery, and follow-up of 250 patients. Laryngoscope 1990;100:79-84.
85Schaitkin B, May M, Shapiro A, Fucci M, Mester SJ. Endoscopic sinus surgery: 4-year follow-up on the first 100 patients. Laryngoscope 1993;103:1117-20.
86Bhattacharyya N. Symptom outcomes after endoscopic sinus surgery for chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2004;130:329-33.
87Danielsen A, Olofsson J. Endoscopic endonasal sinus surgery. A long-term follow-up study. Acta Otolaryngol 1996;116:611-9.
88Damm M, Quante G, Jungehuelsing M, Stennert E. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope 2002;112:310-5.